A carregar...
The pressing questions in multiple sclerosis Care in the era of COVID-19
• MS patients should continue their disease modifying therapy during the pandemic. • Newly diagnosed patients should start disease modifying therapy without delay. • The effect on COVID-19 infection and future vaccination should be considered. • Agents that cause prolonged non-selective lymphopenia...
Na minha lista:
| Publicado no: | J Neurol Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7308765/ https://ncbi.nlm.nih.gov/pubmed/32599294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2020.117005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|